149 patents
Page 2 of 8
Utility
Antiviral Heterocyclic Compounds
13 Apr 23
Adam Szymaniak, Jianming Yu, Kevin McGrath, Xiben Li, Tyler J. Mann, Robert Leon, In Jong Kim, Yat Sun Or, Long Nguyen
Filed: 13 Apr 22
Utility
Novel Spiropyrrolidine Derived Antiviral Agents
6 Apr 23
Guoqiang Wang, Ruichao Shen, Yong He, Jun Ma, Xuechao Xing, Hui Cao, Xuri Gao, Xiaowen Peng, Jiang Long, Wei Li, Jiajun Zhang, Joseph D. Panarese, Nathaniel Thomas Kenton, Samuel Bartlett, Yat Sun Or
Filed: 22 Nov 21
Utility
Antiviral Heterocyclic Compounds
6 Apr 23
Adam Szymaniak, Jianming Yu, Kevin McGRATH, Xiben Li, Tyler J. Mann, Robert Leon, In Jong Kim, Yat Sun Or, Long Nguyen
Filed: 24 Feb 22
Utility
Benzodiazepine Derivatives As RSV Inhibitors
23 Mar 23
Brian C. Shook, In Jong Kim, Thomas P. Blaisdell, Jianming Yu, Joseph D. Panarese, Yat Sun Or
Filed: 3 May 22
Utility
Functionalized Heterocycles As Antiviral Agents
9 Mar 23
Joseph Panarese, Dexter Davis, Samuel Bartlett, Katherine Chong, Nathaniel Kenton, Yat Sun Or
Filed: 3 Nov 21
Utility
Hepatitis B antiviral agents
7 Mar 23
Yao-Ling Qiu, Xuri Gao, Jorden Kass, Hui Cao, Wei Li, Xiaowen Peng, Byung-Chul Suh, Yat Sun Or
Filed: 3 Feb 21
Utility
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
14 Feb 23
Yat Sun Or, Jing He, Guoqiang Wang
Filed: 25 Nov 15
Utility
Antiviral heterocyclic compounds
7 Feb 23
Adam Szymaniak, Kevin McGrath, Jianming Yu, Tyler Mann, Long Nguyen, Kaicheng Zhu, In Jong Kim, Yat Sun Or
Filed: 16 Jul 20
Utility
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
24 Jan 23
Guoqiang Wang, Ruichao Shen, Jiang Long, Jun Ma, Xuechao Xing, Yong He, Brett Granger, Jing He, Bin Wang, Yat Sun Or
Filed: 10 Mar 21
Utility
Isoxazole derivatives as FXR agonists and methods of use thereof
17 Jan 23
Guoqiang Wang, Jun Ma, Bin Wang, Ruichao Shen, Xuechao Xing, Yong He, Yat Sun Or
Filed: 11 May 20
Utility
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
27 Dec 22
Jianming Yu, In Jong Kim, Yat Sun Or
Filed: 6 Jul 21
Utility
Novel Macrocyclic Spiropyrrolidine Derived Antiviral Agents
22 Dec 22
Jiajun Zhang, Xiaowen Peng, Byung-Chul Suh, Jorden Kass, Xuri Gao, Hui Cao, Wei Li, Joseph D. Panarese, Guoqiang Wang, Yat Sun Or
Filed: 13 Apr 22
Utility
Bile Acid Derivatives As FXR/TGR5 Agonists and Methods of Use Thereof
22 Dec 22
Guoqiang Wang, Yat Sun Or, Ruichao Shen, Xuechao Xing, Jiang Long, Peng Dai, Brett Granger, Jing He
Filed: 19 May 21
Utility
Novel Macrocyclic Antiviral Agents
1 Dec 22
Jiajun Zhang, Xiaowen Peng, Yat Sun Or
Filed: 3 May 22
Utility
Antiviral heterocyclic compounds
22 Nov 22
Adam Szymaniak, Kevin McGrath, Jianming Yu, Tyler Mann, Long Nguyen, Kaicheng Zhu, In Jong Kim, Yat Sun Or
Filed: 1 Apr 21
Utility
Antiviral Heterocyclic Compounds
10 Nov 22
Adam Szymaniak, Kevin McGrath, Jianming Yu, Tyler Mann, Long Nguyen, Kaicheng Zhu, In Jong Kim, Yat Sun Or
Filed: 16 Jul 20
Utility
Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
10 Nov 22
Guoqiang Wang, Ruichao Shen, Jiang Long, Jun Ma, Xuechao Xing, Yong He, Brett Granger, Jing He, Bin Wang, Yat Sun Or
Filed: 10 Mar 21
Utility
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
18 Oct 22
Yao-Ling Qiu, Xiaowen Peng, Wei Li, Xuri Gao, Jorden Kass, Byung-Chul Suh, Hui Cao, Jiajun Zhang, Yat Sun Or
Filed: 4 Jun 20
Utility
Combination Pharmaceutical Agents As RSV Inhibitors
13 Oct 22
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.
Brian C. Shook, In Jong Kim, Thomas P. Blaisdell, Jianming Yu, Joseph Panarese, Kai Lin, Michael H.J. Rhodin, Nicole V. McAllister, Yat Sun Or
Filed: 10 Nov 20
Utility
Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
11 Oct 22
Brett Granger, Yong He, Guoqiang Wang, Yat Sun Or
Filed: 24 Mar 20